AG NPP709 is presently available on the market; nonetheless, no examine has investigated the effect of AG NPP709 in patients with COPD. Consequently, the goal of the examine was To judge the efficacy of AG NPP709 in patients with Continual bronchitis variety COPD.Berberine suppresses inflammatory agents-induced interleukin-1beta and tumor necrosis